Mark Edward Christensen - Net Worth and Insider Trading

Mark Edward Christensen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Edward Christensen owns 1 companies in total, including Nu-Med Plus Inc (NUMD) .

Click here to see the complete history of Mark Edward Christensen’s form 4 insider trades.

Insider Ownership Summary of Mark Edward Christensen

Ticker Comapny Transaction Date Type of Owner
NUMD Nu-Med Plus Inc 2015-01-26 CFO & Sec & Treas & Prin Acct Off

Mark Edward Christensen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Edward Christensen Ownership Network

Ownership Network List of Mark Edward Christensen

No Data

Ownership Network Relation of Mark Edward Christensen

Insider Network Chart

Mark Edward Christensen Owned Company Details

What does Nu-Med Plus Inc do?

Who are the key executives at Nu-Med Plus Inc?

Mark Edward Christensen is the CFO & Sec & Treas & Prin Acct Off of Nu-Med Plus Inc. Other key executives at Nu-Med Plus Inc include director & CEO William C Hayde , 10 percent owner Wendy P. Smith , and director & VP of Medical Marketing Brett J. Earl .

Nu-Med Plus Inc (NUMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nu-Med Plus Inc (NUMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nu-Med Plus Inc (NUMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nu-Med Plus Inc (NUMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nu-Med Plus Inc Insider Transactions

No Available Data

Mark Edward Christensen Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Edward Christensen. You might contact Mark Edward Christensen via mailing address: 455 E. 500 S., Suite 207, Salt Lake City Ut 84111.

Discussions on Mark Edward Christensen

No discussions yet.